Prolonged Therapeutic Response to Voriconazole in a Case of Allergic Bronchopulmonary Aspergillosis

Gimeno, R. Bandrés; Martínez, María J. Muñoz

doi:10.1016/s1579-2129(07)60021-4

Cited by 11 publications

(3 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The treatment course is 3–5 months. 66 , 67 The diagnosis procedure and treatment were seen in Figure 3 .…”

Section: Cpa In Copd Patientsmentioning

confidence: 99%

“…To improve symptoms, facilitate weaning from corticosteroids, decrease aspergillus titres and improve radiographic abnormalities and pulmonary function, itraconazole or voriconazole has been suggested in aspergillus sensitisation of COPD patients. The treatment course is 3–5 months 66,67 . The diagnosis procedure and treatment were seen in Figure 3.…”

Section: Cpa In Copd Patientsmentioning

confidence: 99%

See 1 more Smart Citation

Aspergillus infection in chronic obstructive pulmonary diseases

Guo

2023

Clinical Respiratory J

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is a chronic airway non‐specific inflammatory disease characterised by airway obstruction and alveolar destruction. In recent years, due to the extensive use of antibiotics, glucocorticoids, immunosuppressants and other drugs, pulmonary fungal infection in patients with AECOPD, especially aspergillus infection, has gradually increased. The forms of aspergillus infection present in COPD patients include sensitisation, chronic pulmonary aspergillosis (CPA) and invasive pulmonary aspergillosis (IPA). This review will summarise diagnostic and treatment of aspergillus in COPD patients.

show abstract

“…The treatment course is 3–5 months. 66 , 67 The diagnosis procedure and treatment were seen in Figure 3 .…”

Section: Cpa In Copd Patientsmentioning

confidence: 99%

Section: Cpa In Copd Patientsmentioning

confidence: 99%

Aspergillus infection in chronic obstructive pulmonary diseases

Guo

2023

Clinical Respiratory J

View full text Add to dashboard Cite

show abstract

“…Alternative treatments include liposomal or lipid complex form of amphotericin B, caspofungin, micafungin, posaconazole, and itraconazole [3]. The latest Infectious Diseases Society of America guidelines which recommend voriconazole for primary treatment of invasive Aspergillus tracheobronchitis [4], but only few reports on voriconazole for primary treatment of tracheobronchial aspergillosis [5][6][7][8], and evidence is limited. In this study, two cases on the adoption of voriconazole for the treatment of tracheobronchial aspergillosis were observed and reported as follows:…”

Section: Introductionmentioning

confidence: 99%